Summary Despite considerable research we still do not have a comprehensive explanation for the pathogenesis of diabetic neuropathy. Although chronic hyperglycaemia is almost certainly involved, it is not known whether the primary pathology is metabolic, microvascular, or an interaction between the two. Hyperglycaemia-induced polyol pathway hyperactivity associated with nerve sorbitol accumulation and myo-inositol depletion may play a part in the genesis of diabetic neuropathy. The case for microvascular disease in diabetic neuropathy is now strong. Fibre loss in human sural nerve is multifocal, suggesting ischaemia. The degree of vessel disease has been related to the severity of neuropathy. People with chronic obstructive pulmonary disease develop the so called "hypoxic neuropathy" in which similar microvascular changes occur as in diabetic neuropathy. In rats with experimental diabetic neuropathy nerve blood flow is reduced and oxygen supplementation or vasodilator treatment improved the deterioration in conduction velocity and nerve blood flow. Similarly, in human diabetic neuropathy, there is impaired nerve blood flow, epineurial arterio-venous shunting and a reduction in sural nerve oxygen tension. At what stage during the development of nerve damage these changes occur is yet to be determined. [Diabetologia (1994) 37: [847] [848] [849] [850] [851] [852] [853] [854] Key words Diabetic neuropathy, microangiopathy, nerve, hypoxia, blood flow.
Diabetic polyneuropathy commonly leads to considerable morbidity and mortality [1] . The most common neuropathic syndrome associated with diabetes is the distal symmetric, predominantly sensory variety, which is the major initiatng factor for foot ulceration and infection [2] . Neuropathic pain is often disabling, leading to considerable distress and loss of sleep [3] [4] [5] . Conventional treatment is largely symptomatic and frequently ineffective. Yet, the aetiology of this common condition and the mechanisms of neuropathic pain remain obscure [6] [7] [8] . Moreover, we have no reliable means by which we can predict the development, or indeed prevent the progression of clinical diabetic neuropathy [9] . These deficien-cies emphasise the need to pursue the cause of this unpleasant complication. Although there is now a substantial body of evidence for the involvement of chronic hyperglycaemia [10] [11] [12] [13] [14] [15] [16] , it is not known whether metabolic abnormalities directly cause nerve damage (Table 1) or whether they do so by first causing an alteration in nerve microvasculature. In this review we highlight the role of vascular factors in the pathogenesis of diabetic neuropathy (Fig.i) .
Microangiopathy in human diabetic neuropathy
The view that vascular disease may play a part in the pathogenesis of diabetic neuropathy is not recent. In 1893, Price [17] described areas of nerve degeneration in the posterior tibial nerve trunks supplied by severely atheromatous posterior tibial arteries with occlusion of smaller microscopic vessels. Early this cen- Fig. 1 . Some of the proposed microvascular and haemorheological abnormalities leading to endoneurial hypoxia tury, Woltman and Wilder [18] also attributed neuropathy to arteriosclerosis of the vasa nervorum. However, the first detailed study linking diabetic neuropathy to microvascular disease was untertaken by Fagerberg [19] . He demonstrated the presence of thickening and hyalinization of intraneural vessel wall by a material staining positive with periodic acid Schiff. These changes were later found to be due to reduplication of the capillary basal lamina [20] , which may be the result of episodes of increased endothelial cell turnover or indeed due to non-enzymatic glycation [21].
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Several studies have confirmed the presence of endoneurial microangiopathy in both mild and chronic diabetic neuropathy [22] [23] [24] [25] [26] [27] . In a recent sural nerve morphometric study, endoneurial capillary basement membrane (Fig.2) , endothelial cell profile number and total diffusion barrier were found to be significantly increased in diabetic neuropathy [27] . These changes were found to be more severe in endoneurial vessels compared to epineurial [27] muscle [25] or skin [25] capillaries, suggesting an intraneural neurovascular interaction. Furthermore, only the degree of endoneurial vessel disease was related to the severity of both nerve fibre pathology and clinical neuropathy [25], a relationship which has also been reported by other studies [26] .
Endothelial cell hyperplasia has been found in endoneurial capillaries in diabetic neuropathy [28] , in some cases leading to complete occlusion of small vessels (Fig.3) The symmetrical nature of distal, primarily sensory diabetic neuropathy has been used as evidence against the microvascular hypothesis of nerve damage, However, in an autopsy study of 16 diabetic neuropathic subjects, Johnson et al. [35] found focal fascicular lesions characterised by reduced density of myelinated axons within fascicles in the posterior tibial nerve and the lumbosacral trunk. These lesions were found to be identical to those found in biopsies of nerves of non-diabetic subjects with vasculitis. More recently, Beggs et al. [36] from the same unit have demonstrated that diabetic patients have a selective early loss of autonomic innervation in the transperineurial "sleeves" and exaggerated loss of innervation to the larger arterioles in the epineurium. They concluded that autonomic neuropathy of the vasa nervorum leading to impairment of circulatory autoregulation may cause nerve ischaemia. From post-mortem studies, Dyck et al.
[37] also demonstrated that proximal multifocal lesions summate to produce diffuse fibre loss distally in diabetic patients with diStal symmetric neuropathy. In another morphometric and teased fibre study of sural nerve biopsies, Dyck et al. [38] showed that fibre loss is multifocal in diabetic neuropathy, strongly implicating ischaemia as the primary cause.
Perhaps the most compelling evidence for the importance of vascular factors in the aetiology of dia- [41] showed that epineurial vessel intimal area and numbers of intimal nuclei were significantly greater in diabetic subjects, most of whom had neuropathy compared to healthy control subjects. They postulated that these lesions could result in nerve ischaemia although no direct relationship was found between the increase in intima and severity of nerve fibre degeneration.
Experimental nerve ischaemia
Peripheral nerve is supplied by a large network of longitudinal capillaries within the endoneurium and epineurial nutrient arterioles. Because of numerous collateral anastomoses between these two vascular systems, ligation of a single nutrient artery or nutrient arteries of a small segment results in only a partial or patchy ischaemia [42] . This observation has been confirmed by other animal studies [43, 44] . Nukada and Dyck [44] injected microspheres into arteries supplying the sciatic nerve in order to selectively occlude endoneurial vessels, and observed that many microvessels had to be occluded before fibre degeneration resulted. Recently, the acute morphological effect of experimental ischaemia on the ultrastructural features of endoneurial microvessels has been studied in rats [45] . In ischaemic nerves there was an increase in basement membrane, and in the number of pericytes and endothelial cells that appeared swollen. Such studies offer indirect evidence for the importance of microvascular disease in the genesis of nerve damage in diabetes.
Nerve blood flow and oxygen tension: studies in diabetic animals
in recent years there have been a number of animal studies that further strengthen the case for microvascular/hypoxic mechanisms in the pathogenesis of diabetic neuropathy. Laser Dopplerflowmetry. Laser Doppler velocimetry has been employed to measure nerve blood flow [55, 56] . In a recent study, sciatic nerve laser Doppler flux in rats with experimental diabetes was found to be 80 % of that of controls after 4 days of induction of diabetes and steadily fell and formed a plateau at 40 % of control values after 4 weeks [57]. Similar results were obtained in a previous study [56] . Treatment of diabetic rats with insulin prevented the reduction in nerve blood flow [57] . Nerve Doppler flux in BB rats with genetic diabetes of 6 weeks duration was also significantly reduced compared to non-diabetic BB rats [57] .
Injection of radiolabelled microspheres. Recent studies using an alternative method of measuring nerve blood flow by injection of radiolabelled microspheres, have shown an apparently contrary result of increased endoneurial and perineurial sciatic blood flow early after the onset of experimental diabetes [58]. Williamson et al. [59] formulated an hypothesis in which increased oxidation of sorbitol to fructose in vascular cells results in an increase in the cytosolic ratio of NADH/NAD +. This increase in NADH/ NAD + constitutes "pseudohypoxia" without a decrease in tissue pO 2, the vascular response to which is vasodilatation and increased blood flow. This process is then postulated to eventually result in vascular sclerosis and impaired blood flow [59] .
14C butanol~tourniquet method. Monafo et al. [60] found that sciatic nerve blood flow was reduced in diabetic rats by using yet another method which involves intravenous injection of 14C butanol.
As the animal models studied by the various groups are similar, the observed differences in nerve blood flow may only reflect methodological variations.
Nerve oxygen tension and blood flow in human diabetic neuropathy
of nerve blood flow in man. By using novel in vivo techniques of sural nerve photography and fluorescein angiography, recent work has demonstrated the impairment of nerve blood flow and the presence of active epineurial arterio-venous shunts in human diabetic neuropathy [62] , There was wide-spread epineurial vessel abnormality with severe arteriolar attenuation and venous tortuosity and distension. It is not clear whether epineurial arterio-venous shunting [62] is a contributory factor or the result of nerve damage. However, the presence of epineuriaI arterio-venous shunts as well as a fine network of blood vessels resembling the "new vessels" of the retina in subjects with "insulin neuritis" [5], a transient neuropathy that follows rapid improvement in glycaemic control [63] , supports the view that microvascular disease and arterio-venous shunting are causal rather than epiphenomenal factors in the genesis of diabetic neuropathy. An acute onset neuropathy 6 weeks after lowering of blood glucose levels might be expected to be due to metabolic derangement and yet at such an early stage we see such dramatic acute vascular changes [5] . It is well recognised that arterio-venous shunting is a feature of the diabetic neuropathic leg [61, 64, 65] and it seems likely that the same mechanism takes place at the level of the nerve leading to nerve hypoxia. This would be consistent with the observation that nerve fibre degeneration is multifocal in diabetic neuropathy [35, 37, 38] . Loss of sympathetic fibres could result in arteriovenous shunting [36] . Following the demonstration of such shunting in the diabetic limb, similar Doppler sonogram abnormalities and venous oxygenation were found in the limbs of non-diabetic subjects with quadriplegia -total sympathetic denervation [66] .
Recently, exercise-induced conduction velocity increment has been demonstrated to be markedly reduced in diabetic neuropathy [67] . This contrasts with the observation that nerve conduction increases by comparable amounts in both non-neuropathic diabetic and neuropathic diabetic subjects, on direct warming of a limb [67] . The impairment of exerciseinduced conduction velocity increment in diabetic neuropathy is not surprising as the epineurial vessels supplying the neuropathic nerve are severely diseased [62] and consequently nerve blood flow is unlikely to increase after exercise. Exercise-induced conduction velocity increment may therefore be regarded as a non-invasive measure of nerve blood flow.
In human diabetic neuropathy there is a reduction in sural nerve oxygen tension [34] but elevation of PO 2 in foot veins due to arterio-venous shunting [61] . Although histological studies have shown that there are severe microvascular changes at the stage of clinical neuropathy, there have been no in vivo studies
Haemorheological abnormalities
Evidence for the presence of a hypercoagulable state in diabetes is strong. Several studies have suggested that haemorheological abnormalities may contribute to impaired blood flow brought about by microvascu-lar disease [68] . Fibrin deposition [30] and platelet clumping [69] have been observed in endoneurial vessels in diabetic neuropathy. Diabetic erythrocytes have been found to be less deformable than normal [70] and would therefore be expected to travel at a slower velocity in capillaries. This is compounded by increased erythrocyte aggregability and adhesiveness [71] , abnormalities of platelet function, and increased blood and plasma viscosity [72, 73] . According to Poiseuille's Law the rate of flow is proportional to the fourth power of the radius of a vessel. Thus, vessels of low flow such as capillaries are particularly susceptible to episodes of sludging and stasis which if severe, could result in tissue ischaemia. However, the exact causal relationship between haemorheological factors and diabetic complications is not yet clearly understood.
Resistance to ischaemia
An interesting characteristic of the diabetic nerve is what is termed "resistance to ischaemic conduction failure" (RICF). When blood supply is occluded, the diabetic nerve is able to maintain its function as measured by electrophysiological parameters for an abnormally longer period than a normal nerve [74] . This feature has been shown in newly-diagnosed diabetic patients and did not change with satisfactory glycaemic control [75] . When non-diabetic rats are reared in hypoxic conditions they develop RICF [76] , and oxygen supplementation [50] or hyperbaric oxygenation [51] prevents the development of RICF in experimental diabetes. Although the cause remains controversial, a hypoxic mechanism has been forwarded, as RICF which was reversed with improvement of oxygenation was demonstrated in hypoxic subjects with chronic obstructive airways disease [77] . Indeed, people with chronic obstructive airways disease develop a peripheral neuropathy, first described by Appenzeller et al. [78] , in which similar microvascular changes occur as in diabetic neuropathy [79, 80] .
Potential therapeutic approaches
Recently, a number of pharmacological agents that increase nerve blood flow, such as the calcium antagonist nifedipine [81] , the alpha adrenergic receptor blocker prazocin [48] , the nicotinic acid derivative niceritrol [82] , the angiotensin converting enzyme inhibitor lisinopril [49] , and an angiotensin II receptor blocker [83] have been found to improve nerve function in experimental diabetes. Aminoguanidine, which prevents the generation of advanced glycation end-products has been postulated to prevent nerve ischaemia and improve nerve conduction 851 in streptozotocin diabetes by an action in nerve microvessels [84] . Recently, glutathione, a free radical scavenger, has been found to be partially effective in the prevention of diabetic neuropathy in experimental diabetes [85] possibly acting by improving nerve hypoxia [86] . Another recent study has also shown that treatment with the anti-oxidant probucol prevented nerve conduction deficit, reductions in endoneurial blood flow and oxygen tension in streptozotocin diabetic rats [87] . Gamma linolenic acid therapy has also been found to improve neuropathic symptoms and measures of nerve function [88] . There is some evidence that these changes may be due to improvement in nerve blood flow [55, 89] .
In human diabetic neuropathy, a preliminary study by Reja et al. [90] has shown small but significant improvements in electrophysiological and quantitative sensory tests following 12 weeks of treatment with lisinopril. However, this has yet to be confirmed in large, controlled and double-blind trials. Recent observations of impaired nerve blood flow and the striking abnormalities of epineurial nutrient vessels in human diabetic neuropathy [62] , would support that therapeutic measures must also be directed at improving nerve blood flow [91] .
Conclusion
Studies in animal models and in patients with diabetic neuropathy have greatly enhanced our knowledge of diabetic neuropathy. There is little doubt of the presence of severe microvascular changes at the stage of clinical diabetic neuropathy but there is still a large gap in our knowledge of how these changes are initiated. A number of hypotheses including the formation of advanced glycation end products [21], increased oxygen free radical activity [92] and reduced endothelial nitric oxide activity [93, 94] have been forwarded linking chronic hyperglycaemia to microvascular damage. The strong association seen between retinopathy, nephropathy and neuropathy suggests a common pathogenetic mechanism in these complications. Multiple factors are likely to be implicated in the pathogenesis of diabetic polyneuropathy and although metabolic factors are likely to be the source of all diabetic complications, vascular/haemodynamic factors [95] that lead to impairment of function in the retina and the kidney, must now be considered to play an important role in the initiation or promotion of clinical diabetic neuropathy. 
